VERTEX PHARMACEUTICALS INC / MA Total Liabilities 2009-2026 | VRTX
What is total liabilities?
Total liabilities can be defined as the sum of all current and non-current debts and obligations owed by the company.
What is VERTEX PHARMACEUTICALS INC / MA's current total liabilities?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual total liabilities for 2025 was $6.98B, a 13.94% increase from 2024. VERTEX PHARMACEUTICALS INC / MA total liabilities for the quarter ending March 31, 2026 was $7.12B.
What was VERTEX PHARMACEUTICALS INC / MA's total liabilities in 2024?
VERTEX PHARMACEUTICALS INC / MA annual total liabilities for 2024 was $6.12B, a 18.91% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's total liabilities in 2023?
VERTEX PHARMACEUTICALS INC / MA annual total liabilities for 2023 was $5.15B, a 21.51% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year total liabilities CAGR?
VERTEX PHARMACEUTICALS INC / MA total liabilities grew at a compound annual growth rate (CAGR) of 17.88% from FY2020 to FY2025, going from $3.06B to $6.98B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $6.98B | +13.9% | 10-K |
| FY2024 | $6.12B | +18.9% | 10-K |
| FY2023 | $5.15B | +21.5% | 10-K |
| FY2022 | $4.24B | +27.2% | 10-K |
| FY2021 | $3.33B | +8.7% | 10-K |
| FY2020 | $3.06B | +37.2% | 10-K |
| FY2019 | $2.23B | +23.3% | 10-K |
| FY2018 | $1.81B | +20.4% | 10-K |
| FY2017 | $1.50B | -3.5% | 10-K |
| FY2016 | $1.56B | +10.9% | 10-K |
| FY2015 | $1.40B | +13.4% | 10-K |
| FY2014 | $1.24B | +28.7% | 10-K |
| FY2013 | $962.6M | -36.9% | 10-K |
| FY2012 | $1.52B | +23.1% | 10-K |
| FY2011 | $1.24B | +1.4% | 10-K |
| FY2010 | $1.22B | +42.2% | 10-K |
| FY2009 | $859.1M | - | 10-K |